Who made the purchase at $AUPH?

TANG KEVIN C, Chief Executive Officer, is the reporting insider on this Form 4, a purchase of about $12.5M.

Was the $AUPH trade an open-market transaction or a 10b5-1 plan?

The trade was a discretionary, open-market transaction — not executed under a pre-arranged 10b5-1 plan.

What is the DEHY Score for this $AUPH filing?

This filing scored 55 out of 100 on the DEHY Score, a 0–100 triage signal for how much analyst attention a filing warrants — not a price prediction.

← DEHY News

Insider BuyAUPH·Jun 3 · June 3, 2026, 1:55 AM UTC

Aurinia CEO Kevin Tang buys $12.5M of his own stock

The largest open-market insider purchase we structured this week — and it came from the chief executive himself.

Kevin Tang, chief executive of Aurinia Pharmaceuticals, made a multi-million-dollar open-market purchase of AUPH shares. A CEO buying in size on the open market — not exercising options, not on a pre-set schedule — is the single highest-conviction signal in the insider playbook: it is discretionary, it is personal capital, and it is public the moment it files.

Reporting insider: TANG KEVIN C · Chief Executive Officer · discretionary, open-market

The filing, structured

Security	Date	Type	Shares	Price	Owned after	Holding
Common Shares	2026-05-29	Open-market purchase	+2K	$15.35	12.23M	Indirect
Common Shares	2026-05-29	Open-market purchase	+263K	$15.31	12.49M	Indirect
Common Shares	2026-06-01	Open-market purchase	+344K	$15.28	12.84M	Indirect
Common Shares	2026-06-01	Open-market purchase	+99	$15.34	12.84M	Indirect
Common Shares	2026-06-02	Open-market purchase	+206K	$15.28	13.04M	Indirect

DEHY Score 55 / 100Net bought $12.5MView the original Form 4 on SEC EDGAR →

FAQ

What insider transaction did Aurinia Pharmaceuticals Inc. (AUPH) report?: Kevin Tang, chief executive of Aurinia Pharmaceuticals, made a multi-million-dollar open-market purchase of AUPH shares. A CEO buying in size on the open market — not exercising options, not on a pre-set schedule — is the single highest-conviction signal in the insider playbook: it is discretionary, it is personal capital, and it is public the moment it files.
Who made the purchase at $AUPH?: TANG KEVIN C, Chief Executive Officer, is the reporting insider on this Form 4, a purchase of about $12.5M.
Was the $AUPH trade an open-market transaction or a 10b5-1 plan?: The trade was a discretionary, open-market transaction — not executed under a pre-arranged 10b5-1 plan.
What is the DEHY Score for this $AUPH filing?: This filing scored 55 out of 100 on the DEHY Score, a 0–100 triage signal for how much analyst attention a filing warrants — not a price prediction.

Structured from public SEC data within seconds of filing. The DEHY Score is a 0–100 triage signal, not investment advice or a price prediction. See methodology.